Pluri Inc.
PLUR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001158780
No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Pluri Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 17 | 15 | −2 |
| Shares | 63.0K | 45.1K | −17.9K (−28.4%) |
| Value | $364.1K | $272.6K | −$91.5K (−25.1%) |
New holders (1)
Institutions that held Pluri Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 125 | $743 | 0.00% |
Sold out (3)
Institutions that held Pluri Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Jane Street Group, LLC | 12,383 | $71.6K |
| Mather Group, LLC. | 50 | $40 |
| Qube Research & Technologies Ltd | 7 | $40 |